S038 Resident Jeopardy
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
Join your colleagues for self-assessment through this popular, fun and engaging game show format. Contestants representing various residency training programs will face Jeopardy-style queries and image based inquiries encompassing the breadth of dermatology in a friendly competition. Audience members are invited to play along and test their own knowledge. Which institution will emerge as the 2025 AAD Resident Jeopardy champion?
LEARNING OBJECTIVES
Self-assess core competencies across numerous domains in dermatology.
Identify gaps in medical knowledge.
Interact and network with colleagues at similar career levels from various institutions across the country.
SCHEDULE
6:00 PM
Resident Jeopardy
SPEAKERS
Roger Ho, MD, FAAD
Kassandra E Holzem, MD, FAAD
Luke Samuel Johnson, MD, FAAD
Jordan Sy Lim, MD, FAAD
Kiran Motaparthi, MD, FAAD
Michael Stephens, MD, FAAD
Michelle B. Tarbox, MD, FAAD
Lida Zheng, MD, FAAD
SPEAKER DISCLOSURES
Roger Ho, MD, FAAD
Arcutis, Inc. – Advisory Board(Honoraria); EPI Health – Advisory Board(Honoraria); UCB – Advisory Board(Honoraria);
Kassandra E Holzem, MD, FAAD
No financial relationships exist with ineligible companies.
Luke Samuel Johnson, MD, FAAD
Incyte Corporation – Other(Grants/Research Funding); Organon Biosciences SRL – Other(Grants/Research Funding);
Jordan Sy Lim, MD, FAAD
No financial relationships exist with ineligible companies.
Kiran Motaparthi, MD, FAAD
Castle Biosciences, Inc – Consultant(Fees), Investigator(Grants/Research Funding); Proscia – Investigator(Grants/Research Funding);
Michael Stephens, MD, FAAD
No financial relationships exist with ineligible companies.
Michelle B. Tarbox, MD, FAAD
Boehringer Ingelheim – Advisory Board(Honoraria); Castle Biosciences – Investigator(Grants/Research Funding); Dermaleve – Advisory Board(Honoraria); Galderma – Speaker(Honoraria); Novartis – Advisory Board(Honoraria); Sanofi/Regeneron – Investigator(Grants/Research Funding); UCB – Advisory Board(Honoraria);
Lida Zheng, MD, FAAD
No financial relationships exist with ineligible companies.